Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Advertising and Sponsorship
    • Profile & Readership
    • Contact Us
    • Latest News
    • Privacy & Cookies Policies
    • Terms of Use
    • Advertising Terms
    • Issue 81
    • Issue 80
    • Issue 79
    • Issue 78
    • Issue 77
    • Issue 76
    • Issue 75
    • Issue 74
    • Issue 73
    • Issue 72
    • Issue 71
    • Issue 70
    • View All
    • About the Awards
    • Awards Timetable
    • Awards Winners
    • Submit Nominations
    • Testimonials
    • Media Room
    • FAQ
    • Asset Management Awards
    • Brand of the Year Awards
    • Business Awards
    • Cash Management Banking Awards
    • Banking Technology Awards
    • CEO Awards
    • Customer Service Awards
    • CSR Awards
    • Deal of the Year Awards
    • Corporate Governance Awards
    • Corporate Banking Awards
    • Digital Transformation Awards
    • Fintech Awards
    • Education & Training Awards
    • ESG & Sustainability Awards
    • ESG Awards
    • Forex Banking Awards
    • Innovation Awards
    • Insurance & Takaful Awards
    • Investment Banking Awards
    • Investor Relations Awards
    • Leadership Awards
    • Islamic Banking Awards
    • Real Estate Awards
    • Project Finance Awards
    • Process & Product Awards
    • Telecommunication Awards
    • HR & Recruitment Awards
    • Trade Finance Awards
    • The Next 100 Global Awards
    • Wealth Management Awards
    • Travel Awards
    • Years of Excellence Awards
    • Publishing Principles
    • Ownership & Funding
    • Corrections Policy
    • Editorial Code of Ethics
    • Diversity & Inclusion Policy
    • Fact Checking Policy
    Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

    A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

    Copyright © 2010-2026 - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    1. Home
    2. >Headlines
    3. >Doctor pleads guilty to supplying ketamine to 'Friends' star Matthew Perry
    Headlines

    Doctor Pleads Guilty to Supplying Ketamine to 'Friends' Star Matthew Perry

    Published by Global Banking & Finance Review®

    Posted on July 23, 2025

    3 min read

    Last updated: January 22, 2026

    Add as preferred source on Google
    Doctor pleads guilty to supplying ketamine to 'Friends' star Matthew Perry - Headlines news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:insurancefinancial communityfinancial crisisfinancial management

    Quick Summary

    A California doctor pleads guilty to supplying ketamine to 'Friends' star Matthew Perry, raising concerns about medical oversight.

    California Doctor Admits Guilt in Matthew Perry's Ketamine Case

    Legal Proceedings in Matthew Perry's Death

    By Lisa Richwine

    Doctor's Admission and Sentencing

    LOS ANGELES (Reuters) -A California doctor charged in the 2023 overdose death of "Friends" star Matthew Perry pleaded guilty on Wednesday to four counts of illegal distribution of the prescription anesthetic ketamine.

    Implications for Medical Oversight

    Dr. Salvador Plasencia, one of five people charged in the death of Perry at age 54, entered the plea in U.S. District Court in Los Angeles. He faces up to 40 years in prison. 

    Co-defendants and Charges

    Plasencia, 43, will remain free on bond until his sentencing on December 3. He intends to surrender his medical license within 45 days, his attorney said.

    In court, the doctor looked down and patted his face with tissues while answering "yes, your honor" to a series of questions about his actions in the weeks before Perry's death in October 2023.    

    Plasencia admitted to supplying Perry with ketamine, a short-acting anesthetic with hallucinogenic properties. 

    The drug is sometimes prescribed to treat depression and anxiety but is also abused by recreational users. Plasencia acknowledged that he injected Perry with ketamine at the actor's home and in the back seat of a parked car and that doing so was not for legitimate medical purposes.

    Plasencia operated an urgent care clinic and obtained the ketamine from another doctor, Mark Chavez of San Diego. According to court filings, Plasencia texted Chavez about Perry, writing, "I wonder how much this moron will pay."

    Attorneys for Plasencia said the doctor was "profoundly remorseful" for the decisions he made regarding Perry and was "fully accepting responsibility."

    "He hopes his case serves as a warning to other medical professionals and leads to stricter oversight and clear protocols for the rapidly growing at-home ketamine industry in order to prevent future tragedies like this one," his attorneys said in a written statement.

    Chavez and two other co-defendants already have pleaded guilty in the case. None has yet been sentenced.

    A fifth defendant, Jasveen Sangha, whom authorities said was a drug dealer known to customers as the "ketamine queen," has been charged with supplying the dose that killed Perry. She has pleaded not guilty and is scheduled to go on trial in August.

    Perry had publicly acknowledged decades of substance abuse, including during the years he starred as Chandler Bing on the hit 1990s television sitcom "Friends." 

    (Reporting by Lisa Richwine in Los Angeles; Editing by Mary Milliken and Daniel Wallis)

    Table of Contents

    • Legal Proceedings in Matthew Perry's Death
    • Doctor's Admission and Sentencing
    • Implications for Medical Oversight
    • Co-defendants and Charges

    Key Takeaways

    • •California doctor pleads guilty in Matthew Perry's ketamine case.
    • •Doctor faces up to 40 years in prison for illegal distribution.
    • •Ketamine was supplied for non-medical purposes.
    • •The case raises concerns about medical oversight.
    • •Co-defendants have also pleaded guilty in the case.

    Frequently Asked Questions about Doctor pleads guilty to supplying ketamine to 'Friends' star Matthew Perry

    1What charges did Dr. Salvador Plasencia plead guilty to?

    Dr. Salvador Plasencia pleaded guilty to four counts of illegal distribution of ketamine.

    2What is the potential sentence for Dr. Plasencia?

    He faces up to 40 years in prison for his actions related to Matthew Perry's death.

    3What did Plasencia admit regarding his actions with Perry?

    Plasencia admitted to supplying Perry with ketamine and acknowledged injecting him with the drug at the actor's home.

    4What are the implications of this case for medical professionals?

    Plasencia hopes his case serves as a warning to other medical professionals and leads to stricter oversight in the at-home ketamine industry.

    5What is known about Matthew Perry's history with substance abuse?

    Matthew Perry had publicly acknowledged decades of substance abuse, including during his time on the sitcom 'Friends.'

    More from Headlines

    Explore more articles in the Headlines category

    Image for Vance due to visit Hungary on April 7-8 ahead of key election, say sources
    Vance Due to Visit Hungary on April 7-8 Ahead of Key Election, Say Sources
    Image for Belgian police break up migrant smuggling network, four people arrested
    Belgian Police Break up Migrant Smuggling Network, Four People Arrested
    Image for Russia sought to blackmail US using intelligence to Iran, Zelenskiy says
    Russia Sought to Blackmail US Using Intelligence to Iran, Zelenskiy Says
    Image for Italy's tourism minister resigns, ending standoff with PM Meloni
    Italy's Tourism Minister Resigns, Ending Standoff With PM Meloni
    Image for In Lebanon, paramedics mourn their own killed in Israeli strike
    In Lebanon, Paramedics Mourn Their Own Killed in Israeli Strike
    Image for Italy tourism minister resigns, obeying PM Meloni
    Italy Tourism Minister Resigns, Obeying PM Meloni
    Image for Swiss prosecutors not involved with Paris probe at bank Edmond de Rothschild
    Swiss Prosecutors Not Involved With Paris Probe at Bank Edmond De Rothschild
    Image for Lost remains of French musketeer d'Artagnan may have been found in Dutch church
    Lost Remains of French Musketeer d'Artagnan May Have Been Found in Dutch Church
    Image for Doctors in England plan six-day strike after government pay offer rejected
    Doctors in England Plan Six-Day Strike After Government Pay Offer Rejected
    Image for Soccer-Man sentenced for racist abuse of England defender Carter
    Soccer-Man Sentenced for Racist Abuse of England Defender Carter
    Image for Netanyahu seeks to avoid snap vote as Iran war gives no boost in polls
    Netanyahu Seeks to Avoid Snap Vote as Iran War Gives No Boost in Polls
    Image for Cyprus has opened discussion with UK over its bases, president says
    Cyprus Has Opened Discussion With UK Over Its Bases, President Says
    View All Headlines Posts
    Previous Headlines PostColombia's Petro Threatens to Alter Glencore Contract Over Israel Coal Exports
    Next Headlines PostTakeaways of US-Japan Deal Include Potential Gains for Trump, Ishiba and EU